

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The long road to protect infants against severe RSV... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-610/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-610" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The long road to protect infants against severe RSV lower respiratory tract illness" />
    
            <meta name="og:title" content="F1000Research Article: The long road to protect infants against severe RSV lower respiratory tract illness.">
            <meta name="og:description" content="Read the latest article version by Sofia Jares Baglivo, Fernando P Polack, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="20539">
            <meta name="article-id" content="18749">
            <meta name="dc.title" content="The long road to protect infants against severe RSV lower respiratory tract illness">
            <meta name="dc.description" content="Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies.">
            <meta name="dc.subject" content="respiratory syncytial virus, vaccines, monoclonal antibodies, infants, pneumonia, asthma">
            <meta name="dc.creator" content="Jares Baglivo, Sofia">
            <meta name="dc.creator" content="Polack, Fernando P">
            <meta name="dc.date" content="2019/05/02">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.18749.1">
            <meta name="dc.source" content="F1000Research 2019 8:610">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="respiratory syncytial virus">
            <meta name="prism.keyword" content="vaccines">
            <meta name="prism.keyword" content="monoclonal antibodies">
            <meta name="prism.keyword" content="infants">
            <meta name="prism.keyword" content="pneumonia">
            <meta name="prism.keyword" content="asthma">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/05/02">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="610">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.18749.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-610">
            <meta name="citation_title" content="The long road to protect infants against severe RSV lower respiratory tract illness">
            <meta name="citation_abstract" content="Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies.">
            <meta name="citation_description" content="Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies.">
            <meta name="citation_keywords" content="respiratory syncytial virus, vaccines, monoclonal antibodies, infants, pneumonia, asthma">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Sofia Jares Baglivo">
            <meta name="citation_author_institution" content="Fundacion INFANT, Buenos Aires, Argentina">
            <meta name="citation_author" content="Fernando P Polack">
            <meta name="citation_author_institution" content="Fundacion INFANT, Buenos Aires, Argentina">
            <meta name="citation_publication_date" content="2019/05/02">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="610">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.18749.1">
            <meta name="citation_firstpage" content="610">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-610/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-610.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=20539 /> <input type=hidden id=articleId name=articleId value=18749 /> <input type=hidden id=xmlUrl value="/articles/8-610/v1/xml"/> <input type=hidden id=xmlFileName value="-8-610-v1.xml"> <input type=hidden id=article_uuid value=c37f3128-10b8-43bb-9874-ca73cd6e6f1e /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The long road to protect infants against severe RSV lower respiratory tract illness"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.18749.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.18749.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-610"
  },
  "headline": "The long road to protect infants against severe RSV lower respiratory tract illness",
  "datePublished": "2019-05-02T10:31:03",
  "dateModified": "2019-05-02T10:31:03",
  "author": [
    {
      "@type": "Person",
      "name": "Sofia Jares Baglivo"
    },    {
      "@type": "Person",
      "name": "Fernando P Polack"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-610",
            "name": "The long road to protect infants against severe RSV lower respiratory..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The long road to protect infants against severe RSV lower respiratory... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=20539 data-id=18749 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18749.1" data-recommended="" data-doi="10.12688/f1000research.18749.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-610/v1/pdf?article_uuid=c37f3128-10b8-43bb-9874-ca73cd6e6f1e" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-18749-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-18749-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-18749-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Jares Baglivo S and Polack FP. The long road to protect infants against severe RSV lower respiratory tract illness [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):610 (<a class=new-orange href="https://doi.org/10.12688/f1000research.18749.1" target=_blank>https://doi.org/10.12688/f1000research.18749.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-18749-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=18749 id=track-article-signin-18749 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18749?target=/articles/8-610">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20539 /> <input name=articleId type=hidden value=18749 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The long road to protect infants against severe RSV lower respiratory tract illness</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Sofia Jares Baglivo,&nbsp;</span><span class=""><a href="mailto:fernando.p.polack@vanderbilt.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Fernando P Polack</span></a><a href="https://orcid.org/0000-0002-8432-9158" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8432-9158</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Sofia Jares Baglivo,&nbsp;</span><span class=""><a href="mailto:fernando.p.polack@vanderbilt.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Fernando P Polack</span></a><a href="http://orcid.org/0000-0002-8432-9158" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8432-9158</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 02 May 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.18749.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Fundacion INFANT, Buenos Aires, Argentina<br/> <p> <div class=margin-bottom> Sofia Jares Baglivo <br/> <span>Roles: </span> Investigation, Writing  Original Draft Preparation </div> <div class=margin-bottom> Fernando P Polack <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=49978-47661></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=49979-47662></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> respiratory syncytial virus, vaccines, monoclonal antibodies, infants, pneumonia, asthma </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Fernando P Polack (<a href="mailto:fernando.p.polack@vanderbilt.edu">fernando.p.polack@vanderbilt.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Fernando P Polack </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> FPP reports grants and personal fees from Novavax, personal fees from Medimmune, grants and personal fees from Janssen, personal fees from Sanofi, personal fees from Bavarian Nordic, personal fees from Pfizer, personal fees from Merck, personal fees from ArkBio, personal fees from VirBio, personal fees from Regeneron and personal fees from Daiichi Sankyo. SJB reports no conflicts of interest. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by a grant from the Bill & Melinda Gates Foundation (to FPP). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2019 Jares Baglivo S and Polack FP. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Jares Baglivo S and Polack FP. The long road to protect infants against severe RSV lower respiratory tract illness [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):610 (<a href="https://doi.org/10.12688/f1000research.18749.1" target=_blank>https://doi.org/10.12688/f1000research.18749.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 02 May 2019, <b>8</b>(F1000 Faculty Rev):610 (<a href="https://doi.org/10.12688/f1000research.18749.1" target=_blank>https://doi.org/10.12688/f1000research.18749.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 02 May 2019, <b>8</b>(F1000 Faculty Rev):610 (<a href="https://doi.org/10.12688/f1000research.18749.1" target=_blank>https://doi.org/10.12688/f1000research.18749.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><p class="" id=d60762e154>In 1962, following the isolation of the chimpanzee coryza agentlater renamed respiratory syncytial virus (RSV)by Robert Chanock, the first vaccine against RSV was evaluated in 54 children in the US. RSV was inactivated using formalin (FIRSV) and 10 out of 21 vaccine recipients subsequently infected with the virus experienced severe lung disease. No children received placebo, and researchers attributed the observed severity of illness to an unusually bad season<sup><a href="#ref-1">1</a></sup>. Four years later, FIRSV was tested in four clinical trials in young children. Immunized infants developed an enhanced form of disease with severe wheezing and bronchopneumonia when infected with RSV<sup><a href="#ref-1">1</a><a href="#ref-4">4</a></sup>. Hospitalizations were frequent: up to 80% of infected vaccinees in one study<sup><a href="#ref-1">1</a></sup>. Two vaccinated toddlers14 and 16 months of agedied when contracting RSV<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d60762e176>The pathogenesis of enhanced RSV disease (ERD) has been one of the main subjects of interest in the field in the last 50 years. In structural virology and immunology, every significant scientific advancement associated with the virus has been used to uncover new angles of this complex problem. In essence, two immune correlates are accepted as the main determinants of enhancement: the presence of low-avidity, non-protective antibodies elicited by immunization<sup><a href="#ref-5">5</a><a href="#ref-7">7</a></sup> and a polarization of the immune response toward T helper 2 (Th2) in the respiratory tract after RSV infection<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Non-protective antibodies form pathogenic immune complexes in the lung that lead to complement activation and simultaneously fail to inhibit RSV replication. T helper lymphocytes polarized to type 2 responses after vaccination trigger an exuberant pulmonary infiltrate characterized by an excess in eosinophils and neutrophils. Recent observations in the field postulate a potential relationship between RSV F conformations in the vaccine and ERD<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>; new findings question whether route of immunization may be important for RSV vaccine responses<sup><a href="#ref-12">12</a></sup>; and improvements in our understanding of IgG memory B cells that have not undergone affinity maturation may help identify primed B-cell memory populations associated with disease enhancement<sup><a href="#ref-13">13</a><a href="#ref-15">15</a></sup>. Moreover, subpopulations of individuals with genetic mutations in molecules essential to B-cell maturation interrogate whether ERD could ever be observed in seropositive subjects<sup><a href="#ref-16">16</a><a href="#ref-18">18</a></sup>.</p><p class="" id=d60762e219>Given that memory T helper cells play a critical role in the severity of ERD presentations, approaches to RSV prophylaxis that rely on passive acquisition of antibody are unlikely to trigger adverse responses of extreme severity. Immunization of pregnant women to protect infants through transplacental transfer of antibody and administration of virus-specific monoclonal antibodies (mAbs) of extended half-life<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup> have undergone numerous phase 1 and phase 2 evaluations without evidence of ERD<sup><a href="#ref-21">21</a><a href="#ref-23">23</a></sup>. In addition, infant intranasal immunization with live-attenuated RSV vaccines (LAVs) mimics natural infection and has not been associated with ERD in phase 1 trials in seronegative subjects<sup><a href="#ref-24">24</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d60762e243>Circumventing enhanced respiratory syncytial virus disease</h2><p class="" id=d60762e246>After the adverse outcomes resulting from FIRSV immunization in 1967<sup><a href="#ref-1">1</a></sup>, the RSV field focused on preventive strategies that excluded immunization of seronegative infants and young children with non-replicating RSV vaccines. The first LAV was developed at the National Institute of Allergy and Infectious Diseases (NIAID) in 1969. Evaluation of purified F protein (that is, PFP-2) in pregnant women failed to elicit sufficient antibody to achieve high levels of IgG transplacental transfer in the past<sup><a href="#ref-25">25</a></sup>. Passive transfer of sera enriched for anti-RSV F antibodies (RespiGam<sup></sup>)<sup><a href="#ref-26">26</a></sup> was followed by licensing of a humanized neutralizing mAb targeting site II of RSV F (that is, palivizumab) to prevent illness in infants at high risk for severe disease with 55% efficacy (tested in infants younger than 33 weeks of gestational age at birth)<sup><a href="#ref-27">27</a></sup>. This widely accepted approach to RSV disease prevention has limitations: it is costly for developing countries, requires monthly administration in young infants (often compromising compliance), and demands a good characterization of the circulating RSV strains and a clear understanding of the RSV season in tropical climates. In addition, results from the initial phase 3 clinical trial of palivizumab suggest that certain specific populations may be more challenging to protect than others. For instance, about 90% of all palivizumab treatment failures were heterozygotes for a loss-of-function single-nucleotide polymorphism in Asp299Gly or Thr399Ile (or both) of the pattern recognition receptor Toll-like receptor 4 (TLR4<sup>+/</sup>)<sup><a href="#ref-28">28</a></sup>. These TLR4<sup>+/</sup> infants represent only about 10% of the US population and experience exaggerated Th2 responses in the respiratory tract during RSV infection<sup><a href="#ref-29">29</a></sup>. Also, in children from Navajo and Apache reservations, who are particularly susceptible to RSV<sup><a href="#ref-30">30</a></sup>, a second-generation high-affinity mAb against the virus did not prevent long-term recurrent wheezing (see below) despite reducing the rate of severe acute RSV disease<sup><a href="#ref-31">31</a></sup>. Thus, palivizumab remains the only licensed approach to RSV prevention today.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d60762e294>Mapping severe respiratory syncytial virus lower respiratory tract illness and its long-term consequences</h2><p class="" id=d60762e297>In the last decade, the field of RSV vaccines has witnessed an exponential growth of novel strategies and improvements in pre-existing approaches to tame this elusive virus (<a target=xrefwindow href="https://path.azureedge.net/media/documents/RSV_Snapshot_2019_03_29_High_Resolution.pdf" id=d60762e299>https://path.azureedge.net/media/documents/RSV_Snapshot_2019_03_29_High_Resolution.pdf</a>). These developments were coupled with a better understanding of disease biology and burden of illness worldwide. Studies from groups in Spain and the US identified a pre-fusion conformation in RSV F that exposed several protective epitopes and fostered development of new vaccines and mAb<sup><a href="#ref-32">32</a></sup>. Meanwhile, large global collaborative studies reported more than three million hospitalizations every year directly attributed to RSV along with about 118,000 deaths at the hospitals and in the community<sup><a href="#ref-33">33</a></sup>. Deaths in industrialized countries were infrequent and associated with chronic illness, from chronic lung disease and cyanotic congenital heart disease to neuromuscular or genetic disorders or both<sup><a href="#ref-34">34</a></sup>. In the developing world, deaths at the hospital often followed mechanical problems during medical carethat is, clinically significant pneumothoraxes (air leaks compromising oxygenation)and secondary bacterial infections with Gram-positive cocci<sup><a href="#ref-35">35</a></sup>. Deaths in the community affected families in vulnerable socioeconomic situations who often did not visit medical facilities<sup><a href="#ref-36">36</a></sup>. Recent observations during the phase 3 evaluation of a maternal F nanoparticle vaccine to prevent RSV lower respiratory tract illness (LRTI) in young infants that failed to meet its primary endpoint may lead to revision of the estimated burden of RSV in the developing world. Interestingly, passively immunized infants had an unexpected reduction in all-cause medically significant (MS) LRTI, suggesting that RSV may be at play in circumstances we do not anticipate<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d60762e328>In addition, through prevention of RSV LRTI using palivizumab, a landmark study in premature babies showed that severe RSV LRTI also contributes to the inception of recurrent wheezing and potentially asthma in children<sup><a href="#ref-38">38</a></sup>. Other studies also examined the role of RSV in long-term wheezing and asthma through trials using mAb<sup><a href="#ref-31">31</a>,<a href="#ref-39">39</a><a href="#ref-41">41</a></sup>. The majority of these studies described a protective role against recurrent wheezing for RSV prevention using palivizumab in the first year of life<sup><a href="#ref-38">38</a><a href="#ref-41">41</a></sup>. Interestingly, a similar study with a high-affinity mAb against RSV (motavizumab) in healthy Native Americans born at term in Arizona had no effect on rates of medically attended wheezing in 1- to 3-year-old children despite preventing severe acute RSV LRTI<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d60762e356>Most of these studies monitoring wheezing reported a follow-up at the age of 6 years. In the Netherlands, palivizumab significantly reduced parent-reported asthma on the basis of different rates in infrequent wheezing (one to three episodes per year) when compared with placebo recipients<sup><a href="#ref-42">42</a></sup>. Physician-diagnosed asthma and lung function did not differ between groups<sup><a href="#ref-42">42</a></sup>. In Japan, palivizumab prophylaxis did not suppress the onset of atopic asthma but did reduce recurrent wheezing<sup><a href="#ref-41">41</a></sup>. In recent years, a group of investigators proposed a set of clinical criteria and lung function evaluations (forced oscillation technique at the age of 3 years and spirometry at the age of 6 years) for the evaluation of recurrent wheezing and asthma in clinical trials<sup><a href="#ref-43">43</a></sup>. Evidently, ongoing vaccine and mAb phase 3 studies represent a unique opportunity to answer these questions and settle the precise role of RSV in asthma inception. Yet asthma has proven to be a set of heterogeneous conditions with different molecular mechanisms of illness but common symptoms. These overlapping clinical phenotypes with distinct mechanisms of illness are known as asthma endotypes<sup><a href="#ref-44">44</a></sup>. Hence, it is probable that preventing severe RSV disease will modulate one or a few of these asthma endotypes but not influence others. (In fact, the lack of association between RSV and atopy is fairly well established<sup><a href="#ref-45">45</a></sup>.) Today, there is enough evidence to warrant a detailed evaluation of a role for RSV vaccines and mAbs in decreasing the burden of all-cause severe LRTI and pneumonia after RSV-specific antibodies become undetectable in serum<sup><a href="#ref-35">35</a><a href="#ref-37">37</a></sup>, having a greater-than-expected impact on mortality at the hospital and in the community given the aforementioned effects<sup><a href="#ref-35">35</a><a href="#ref-37">37</a></sup>, and modulating the burden of recurrent wheezing with potential long-term consequences in lung function and perhaps certain endotypes of asthma in school-age children<sup><a href="#ref-39">39</a><a href="#ref-41">41</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d60762e408>Surge of approaches to prevent respiratory syncytial virus lower respiratory tract illness</h2><p class="" id=d60762e411>There are three target populations that concentrate most efforts in RSV vaccine and mAb development. First, infants under 6 months of age constitute the main at-risk group. For them, two approaches are under consideration: passive transfer of protective antibody following maternal immunization and early administration of mAb of extended half-life. Second, in older children, active immunization with LAV or vectored vaccines is expected to extend protection through the first year(s) of life. Finally, adults older than 65 years may experience disease rates comparable to those elicited by influenza virus and are targeted for protection using active immunization with different constructs. Preventive strategies for the latter group are beyond the scope of this review, but it is important to note that two consecutive trials by Novavax and MedImmune failed to confer protection against medically attended RSV LRTI in the elderly with primary endpoint efficacies of 7.9% (95% confidence interval [CI] 84 to 37%) and 7.1% (95% CI 106.9 to 44.3%), respectively<sup><a href="#ref-46">46</a><a href="#ref-48">48</a></sup>.</p><p class="" id=d60762e421>Maternal immunization, after the widespread incorporation of influenza and pertussis vaccines to calendars, has been increasingly accepted as a strategy to provide protection to infants during their most vulnerable period. Maternal IgG antibodies are transferred across the placenta to fetal circulation through an active Fc receptormediated process during the third trimester of pregnancy and are expected to prevent severe disease inception in young infants. Recently, Novavax reported preliminary results from their evaluation of a pre-fusogenic nanoparticle vaccine in a randomized controlled trial in about 4,600 pregnant women immunized at a ratio of 2:1 between vaccinees and placebo recipients. This first-ever phase 3 study failed to meet its primary endpoint but exhibited 39.4% (95% CI 5.3 to 61.2%) efficacy at 90 days in reducing MS RSV LRTI globally with 44.4% (95% CI 19.6 to 61.5%) reduction in hospitalizations. The vaccine was safe with no observed difference in adverse events between vaccine and placebo recipients. Interestingly, results exhibited considerably more efficacy in South Africa than in the US: a pre-specified exploratory MS-RSV LRTI endpoint including additional cases retrieved from hospital chart reviews ranged from 57% (95% CI 32.7 to 72.5%) to 32.7% (95% CI 238.9 to 48.1%). Unfortunately, the study was not sufficiently powered to confidently ascertain whether these differences simply represent variations within the CI or respond to other mechanisms. Immunization more than 30 days before delivery enhanced the efficacy of the vaccine<sup><a href="#ref-37">37</a></sup>. Importantly, the Novavax RSV pre-fusogenic vaccine conferred protection against two additional pre-specific endpoints: 25.3% against all-cause LRTI and 39.1% against all-cause LRTI with significant hypoxemia (&lt;92% O<sub>2</sub> saturation) globally<sup><a href="#ref-37">37</a></sup>. Other maternal immunogens include a GlaxoSmithKline recombinant RSV protein F vaccine, engineered to preferentially maintain pre-fusion conformation (NCT02753413)<sup><a href="#ref-19">19</a>,<a href="#ref-49">49</a></sup>; a Pfizer subunit vaccine encoding a stabilized pre-fusion molecule also intended for the elderly (NCT03529773)<sup><a href="#ref-21">21</a></sup>; and the RSV F DS-Cav1 (NCT03049488) candidate developed by the NIAID<sup><a href="#ref-50">50</a></sup>. This last formulation engineered soluble site stabilized RSV F trimers (site  is present on pre-fusion F only) adjuvanted with alum.</p><p class="" id=d60762e451>Development of mAb against RSV has also faced considerable challenges in recent years. Motavizumab, a second-generation mAb of high potency derived from palivizumab by MedImmune using affinity maturation techniques, reduced by 87% (95% CI 79 to 92%) the incidence of hospitalization due to RSV and outpatient visits by 71% (95% CI 58 to 80%) in term infants not older than 6 months of age in Navajo and Apache reservations<sup><a href="#ref-31">31</a></sup>. However, the drug exhibited serious adverse eventsincluding hypersensitivity or allergic events, erythema multiforme, and a self-resolving transient skin erythemaprobably associated with the study product<sup><a href="#ref-31">31</a></sup>. Evaluation of suptavumab (REGN2222), an antibody of extended half-life developed by Regeneron against site V in RSV F, failed to meet its primary efficacy endpoint in preterm infants (NCT02325791)<sup><a href="#ref-51">51</a></sup>. Despite presenting a protective trend against medically attended infections caused by RSV subgroup A, an unexpected mutation in site V of RSV F in circulating RSV B viruses affected its overall performance.</p><p class="" id=d60762e466>MedImmune, the manufacturer of palivizumab, is now evaluating MEDI8897, timed to enter phase 3 trials in the coming year. MEDI8897 presents amino acid substitutions in the Fc regionMet252Tyr/Ser254Thr/Thr256Glu (YTE technology)that augment binding to the histocompatibility complex class I-neonatal Fc receptor and extend its half-life to 85 to 117 days<sup><a href="#ref-52">52</a><a href="#ref-55">55</a></sup>. This attractive candidate received breakthrough therapy designation from the US Food and Drug Administration and aims to protect infants against RSV with a single injection. The mAb targets antigenic site  in the pre-fusion conformation of RSV F. Another mAb of extended half-life undergoing evaluation is MK-1654 from Merck (NCT03524118) targeting RSV F site IV<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d60762e481>For older children, there are several live-attenuated vaccines in clinical trials, all of them in phase 1. A candidate from NIAID-Sanofi with an NS2 non-structural protein deletion that reduces viral suppression of the interferon response and increases the innate immune response has advanced in parallel with a second NIAID-Sanofi candidate with a deletion in the RSV M2-2 protein attenuating viral replication while upregulating gene transcription and antigen expression (NCT02237209 and NCT02040831)<sup><a href="#ref-57">57</a><a href="#ref-62">62</a></sup>. These candidates appear mildly over- and under-attenuated, respectively<sup><a href="#ref-61">61</a></sup>. Vectored approaches for children include Ad26.RSV.preF using a human adenovirus 26 now in phase 2 trials in adults and 12- to 24-month-old RSV seropositive toddlers (NCT03303625)<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup> and ChAd155-RSV (NCT02927873)<sup><a href="#ref-65">65</a></sup>, a replication-incompetent chimpanzee adenovirus 155 now in phase 2 in seropositive children. This vector encodes the F, N, and M2-1 RSV proteins<sup><a href="#ref-65">65</a></sup>. MVA-BN-RSV from Bavarian Nordic uses modified vaccinia Ankara virus encoding F, G, N, and M2-1 antigens and has completed phase 2 in adults. Finally, the rBCG-N-hRSV vaccine (NCT03213405)<sup><a href="#ref-66">66</a></sup> is a chimeric candidate using recombinant BCG expressing RSV N protein and is targeted for use in newborns. This BCG construct would allow simultaneous early protection against two serious ailments while inducing Th1 immunity, skewing responses away from the undesirable Th2 priming typical of ERD<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. In addition, rBCG-N-hRSV is expected to elicit cellular immunity against RSV<sup><a href="#ref-68">68</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d60762e529>Final considerations</h2><p class="" id=d60762e532>Prevention of severe RSV LRTI has proven challenging for various approaches, but recent results from maternal immunization using ResVax<sup></sup> and the effectiveness of palivizumab demonstrate that conferring some degree of protection is possible. Numerous strategies are advancing through human trials. Studies in the next few years should contribute to better contextualize the benefits of each successful existing and upcoming intervention.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d60762e1 class=n-a></a><h2 class=main-title id=d60922>Grant information</h2><p>This work was supported by a grant from the Bill &amp; Melinda Gates Foundation (to FPP).</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i></p></div><div class=back-section><a name=d60762e542 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d61133>References</h2><div class="section ref-list"><a name=d60762e542 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d60762e549 class=n-a></a>Kim HW, Canchola JG, Brandt CD, <i> et al.</i>: Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. <i>Am J Epidemiol.</i> 1969; <b>89</b>(4): 42234. <a target=xrefwindow id=d60762e560 href="http://www.ncbi.nlm.nih.gov/pubmed/4305198">PubMed Abstract </a> | <a target=xrefwindow id=d60762e563 href="https://doi.org/10.1093/oxfordjournals.aje.a120955">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d60762e572 class=n-a></a>Chin J, Magoffin RL, Shearer LA, <i> et al.</i>: Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. <i>Am J Epidemiol.</i> 1969; <b>89</b>(4): 44963. <a target=xrefwindow id=d60762e583 href="http://www.ncbi.nlm.nih.gov/pubmed/4305200">PubMed Abstract </a> | <a target=xrefwindow id=d60762e586 href="https://doi.org/10.1093/oxfordjournals.aje.a120957">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d60762e595 class=n-a></a>Kapikian AZ, Mitchell RH, Chanock RM, <i> et al.</i>: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. <i>Am J Epidemiol.</i> 1969; <b>89</b>(4): 40521. <a target=xrefwindow id=d60762e606 href="http://www.ncbi.nlm.nih.gov/pubmed/4305197">PubMed Abstract </a> | <a target=xrefwindow id=d60762e609 href="https://doi.org/10.1093/oxfordjournals.aje.a120954">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d60762e618 class=n-a></a>Fulginiti VA, Eller JJ, Sieber OF, <i> et al.</i>: Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. <i>Am J Epidemiol.</i> 1969; <b>89</b>(4): 43548. <a target=xrefwindow id=d60762e629 href="http://www.ncbi.nlm.nih.gov/pubmed/4305199">PubMed Abstract </a> | <a target=xrefwindow id=d60762e632 href="https://doi.org/10.1093/oxfordjournals.aje.a120956">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1146889"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e641 class=n-a></a>Delgado MF, Coviello S, Monsalvo AC, <i> et al.</i>: Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. <i>Nat Med.</i> 2009; <b>15</b>(1): 3441. <a target=xrefwindow id=d60762e652 href="http://www.ncbi.nlm.nih.gov/pubmed/19079256">PubMed Abstract </a> | <a target=xrefwindow id=d60762e655 href="https://doi.org/10.1038/nm.1894">Publisher Full Text </a> | <a target=xrefwindow id=d60762e659 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2987729">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1146889">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1009529"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e673 class=n-a></a>Polack FP, Teng MN, Collins PL, <i> et al.</i>: A role for immune complexes in enhanced respiratory syncytial virus disease. <i>J Exp Med.</i> 2002; <b>196</b>(6): 85965. <a target=xrefwindow id=d60762e684 href="http://www.ncbi.nlm.nih.gov/pubmed/12235218">PubMed Abstract </a> | <a target=xrefwindow id=d60762e687 href="https://doi.org/10.1084/jem.20020781">Publisher Full Text </a> | <a target=xrefwindow id=d60762e691 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2194058">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1009529">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d60762e704 class=n-a></a>Acosta PL, Caballero MT, Polack FP: Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease. <i>Clin Vaccine Immunol.</i> 2015; <b>23</b>(3): 18995. <a target=xrefwindow id=d60762e712 href="http://www.ncbi.nlm.nih.gov/pubmed/26677198">PubMed Abstract </a> | <a target=xrefwindow id=d60762e715 href="https://doi.org/10.1128/CVI.00609-15">Publisher Full Text </a> | <a target=xrefwindow id=d60762e718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4783420">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725388503"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e727 class=n-a></a>Knudson CJ, Hartwig SM, Meyerholz DK, <i> et al.</i>: RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets. <i>PLoS Pathog.</i> 2015; <b>11</b>(3): e1004757. <a target=xrefwindow id=d60762e738 href="http://www.ncbi.nlm.nih.gov/pubmed/25769044">PubMed Abstract </a> | <a target=xrefwindow id=d60762e741 href="https://doi.org/10.1371/journal.ppat.1004757">Publisher Full Text </a> | <a target=xrefwindow id=d60762e745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4358888">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725388503">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d60762e758 class=n-a></a>Graham BS, Henderson GS, Tang YW, <i> et al.</i>: Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. <i>J Immunol.</i> 1993; <b>151</b>(4): 203240. <a target=xrefwindow id=d60762e769 href="http://www.ncbi.nlm.nih.gov/pubmed/8345194">PubMed Abstract </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d60762e778 class=n-a></a>McLellan JS, Ray WC, Peeples ME: Structure and function of respiratory syncytial virus surface glycoproteins. <i>Curr Top Microbiol Immunol.</i> 2013; <b>372</b>: 83104. <a target=xrefwindow id=d60762e786 href="http://www.ncbi.nlm.nih.gov/pubmed/24362685">PubMed Abstract </a> | <a target=xrefwindow id=d60762e789 href="https://doi.org/10.1007/978-3-642-38919-1_4">Publisher Full Text </a> | <a target=xrefwindow id=d60762e792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4211642">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726785585"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e801 class=n-a></a>Killikelly AM, Kanekiyo M, Graham BS: Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. <i>Sci Rep.</i> 2016; <b>6</b>: 34108. <a target=xrefwindow id=d60762e809 href="http://www.ncbi.nlm.nih.gov/pubmed/27682426">PubMed Abstract </a> | <a target=xrefwindow id=d60762e812 href="https://doi.org/10.1038/srep34108">Publisher Full Text </a> | <a target=xrefwindow id=d60762e815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5040956">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726785585">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725339619"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e829 class=n-a></a>De Silva NS, Klein U: Dynamics of B cells in germinal centres. <i>Nat Rev Immunol.</i> 2015; <b>15</b>(3): 13748. <a target=xrefwindow id=d60762e837 href="http://www.ncbi.nlm.nih.gov/pubmed/25656706">PubMed Abstract </a> | <a target=xrefwindow id=d60762e840 href="https://doi.org/10.1038/nri3804">Publisher Full Text </a> | <a target=xrefwindow id=d60762e843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4399774">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725339619">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726090831"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e856 class=n-a></a>Weisel FJ, Zuccarino-Catania GV, Chikina M, <i> et al.</i>: A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells. <i>Immunity.</i> 2016; <b>44</b>(1): 11630. <a target=xrefwindow id=d60762e867 href="http://www.ncbi.nlm.nih.gov/pubmed/26795247">PubMed Abstract </a> | <a target=xrefwindow id=d60762e870 href="https://doi.org/10.1016/j.immuni.2015.12.004">Publisher Full Text </a> | <a target=xrefwindow id=d60762e874 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4724390">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726090831">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718513760"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e887 class=n-a></a>Duan Z, Chen X, Liang Z, <i> et al.</i>: Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine. <i>Vaccine.</i> 2014; <b>32</b>(41): 531622. <a target=xrefwindow id=d60762e898 href="http://www.ncbi.nlm.nih.gov/pubmed/25077417">PubMed Abstract </a> | <a target=xrefwindow id=d60762e901 href="https://doi.org/10.1016/j.vaccine.2014.07.064">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718513760">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8928959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e914 class=n-a></a>Morita R, Schmitt N, Bentebibel SE, <i> et al.</i>: Human blood CXCR5<sup>+</sup>CD4<sup>+</sup> T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. <i>Immunity.</i> 2011; <b>34</b>(1): 10821. <a target=xrefwindow id=d60762e932 href="http://www.ncbi.nlm.nih.gov/pubmed/21215658">PubMed Abstract </a> | <a target=xrefwindow id=d60762e935 href="https://doi.org/10.1016/j.immuni.2010.12.012">Publisher Full Text </a> | <a target=xrefwindow id=d60762e938 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3046815">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8928959">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d60762e951 class=n-a></a>Choi YS, Yang JA, Crotty S: Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells. <i>Curr Opin Immunol.</i> 2013; <b>25</b>(3): 36672. <a target=xrefwindow id=d60762e959 href="http://www.ncbi.nlm.nih.gov/pubmed/23688737">PubMed Abstract </a> | <a target=xrefwindow id=d60762e962 href="https://doi.org/10.1016/j.coi.2013.04.003">Publisher Full Text </a> | <a target=xrefwindow id=d60762e965 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3763739">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d60762e974 class=n-a></a>Kim ST, Choi JY, Lainez B, <i> et al.</i>: Human Extrafollicular CD4<sup>+</sup> Th Cells Help Memory B Cells Produce Igs. <i>J Immunol.</i> 2018; <b>201</b>(5): 135972. <a target=xrefwindow id=d60762e988 href="http://www.ncbi.nlm.nih.gov/pubmed/30030323">PubMed Abstract </a> | <a target=xrefwindow id=d60762e992 href="https://doi.org/10.4049/jimmunol.1701217">Publisher Full Text </a> | <a target=xrefwindow id=d60762e995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6112860">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d60762e1005 class=n-a></a>Connors M, Kulkarni AB, Firestone CY, <i> et al.</i>: Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. <i>J Virol.</i> 1992; <b>66</b>(12): 744451. <a target=xrefwindow id=d60762e1016 href="http://www.ncbi.nlm.nih.gov/pubmed/1433525">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1019 href="http://www.ncbi.nlm.nih.gov/pmc/articles/240452">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d60762e1028 class=n-a></a>Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1030 href="https://clinicaltrials.gov/ct2/show/NCT02753413">Reference Source</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d60762e1039 class=n-a></a>Beran J, Lickliter JD, Schwarz TF, <i> et al.</i>: Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials. <i>J Infect Dis.</i> 2018; <b>217</b>(10): 161625. <a target=xrefwindow id=d60762e1050 href="http://www.ncbi.nlm.nih.gov/pubmed/29401325">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1053 href="https://doi.org/10.1093/infdis/jiy065">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5913599">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d60762e1066 class=n-a></a>Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine Pfizer: One of the worlds premier biopharmaceutical companies. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1068 href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_begins_a_phase_1_2_study_to_evaluate_respiratory_syncytial_virus_rsv_vaccine-0">Reference Source</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d60762e1077 class=n-a></a>A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization. ClinicalTrials.gov. (Accessed: 23rd February 2019). <a target=xrefwindow id=d60762e1079 href="https://clinicaltrials.gov/ct2/show/NCT02624947">Reference Source</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d60762e1088 class=n-a></a>A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1090 href="https://clinicaltrials.gov/ct2/show/NCT03529773">Reference Source</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d60762e1100 class=n-a></a>Wright PF, Karron RA, Belshe RB, <i> et al.</i>: The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. <i>Vaccine.</i> 2007; <b>25</b>(42): 73728. <a target=xrefwindow id=d60762e1111 href="http://www.ncbi.nlm.nih.gov/pubmed/17868959">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1114 href="https://doi.org/10.1016/j.vaccine.2007.08.014">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1118 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2760483">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d60762e1127 class=n-a></a>Englund J, Glezen WP, Piedra PA: Maternal immunization against viral disease. <i>Vaccine.</i> 1998; <b>16</b>(1415): 145663. <a target=xrefwindow id=d60762e1135 href="http://www.ncbi.nlm.nih.gov/pubmed/9711788">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1138 href="https://doi.org/10.1016/S0264-410X(98)00108-X">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d60762e1147 class=n-a></a>Groothuis JR, Simoes EA, Levin MJ, <i> et al.</i>: Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. <i>N Engl J Med.</i> 1993; <b>329</b>(21): 152430. <a target=xrefwindow id=d60762e1158 href="http://www.ncbi.nlm.nih.gov/pubmed/8413475">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1161 href="https://doi.org/10.1056/NEJM199311183292102">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d60762e1170 class=n-a></a>The IMpact-RSV Study Group: Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. <i>Pediatrics.</i> 1998; <b>102</b>(3): 5317. <a target=xrefwindow id=d60762e1178 href="http://www.ncbi.nlm.nih.gov/pubmed/9724660">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1181 href="https://doi.org/10.1542/peds.102.3.531">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d60762e1190 class=n-a></a>Awomoyi AA, Rallabhandi P, Pollin TI, <i> et al.</i>: Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. <i>J Immunol.</i> 2007; <b>179</b>(5): 31717. <a target=xrefwindow id=d60762e1201 href="http://www.ncbi.nlm.nih.gov/pubmed/17709532">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1204 href="https://doi.org/10.4049/jimmunol.179.5.3171">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725296581"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1213 class=n-a></a>Caballero MT, Serra ME, Acosta PL, <i> et al.</i>: <i>TLR4</i> genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. <i>J Clin Invest.</i> 2015; <b>125</b>(2): 57182. <a target=xrefwindow id=d60762e1227 href="http://www.ncbi.nlm.nih.gov/pubmed/25555213">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1231 href="https://doi.org/10.1172/JCI75183">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1234 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4319428">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725296581">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d60762e1248 class=n-a></a>Bockova J, O'Brien KL, Oski J, <i> et al.</i>: Respiratory syncytial virus infection in Navajo and White Mountain Apache children. <i>Pediatrics.</i> 2002; <b>110</b>(2 Pt 1): e20. <a target=xrefwindow id=d60762e1259 href="http://www.ncbi.nlm.nih.gov/pubmed/12165619">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1262 href="https://doi.org/10.1542/peds.110.2.e20">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725888977"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1271 class=n-a></a>O'Brien KL, Chandran A, Weatherholtz R, <i> et al.</i>: Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial. <i>Lancet Infect Dis.</i> 2015; <b>15</b>(12): 1398408. <a target=xrefwindow id=d60762e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/26511956">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1285 href="https://doi.org/10.1016/S1473-3099(15)00247-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725888977">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718163219"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1298 class=n-a></a>McLellan JS, Chen M, Joyce MG, <i> et al.</i>: Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. <i>Science.</i> 2013; <b>342</b>(6158): 5928. <a target=xrefwindow id=d60762e1309 href="http://www.ncbi.nlm.nih.gov/pubmed/24179220">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1312 href="https://doi.org/10.1126/science.1243283">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1316 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4461862">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718163219">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727795780"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1329 class=n-a></a>Shi T, McAllister DA, O'Brien KL, <i> et al.</i>: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. <i>Lancet.</i> 2017; <b>390</b>(10098): 94658. <a target=xrefwindow id=d60762e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/28689664">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1343 href="https://doi.org/10.1016/S0140-6736(17)30938-8">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1347 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5592248">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727795780">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725270136"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1360 class=n-a></a>Byington CL, Wilkes J, Korgenski K, <i> et al.</i>: Respiratory syncytial virus-associated mortality in hospitalized infants and young children. <i>Pediatrics.</i> 2015; <b>135</b>(1): e2431. <a target=xrefwindow id=d60762e1371 href="http://www.ncbi.nlm.nih.gov/pubmed/25489019">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1374 href="https://doi.org/10.1542/peds.2014-2151">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1378 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4279071">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725270136">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d60762e1391 class=n-a></a>Geoghegan S, Erviti A, Caballero MT, <i> et al.</i>: Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors. <i>Am J Respir Crit Care Med.</i> 2017; <b>195</b>(1): 96103. <a target=xrefwindow id=d60762e1402 href="http://www.ncbi.nlm.nih.gov/pubmed/27331632">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1405 href="https://doi.org/10.1164/rccm.201603-0658OC">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d60762e1415 class=n-a></a>Caballero MT, Bianchi AM, Nuo A, <i> et al.</i>: Mortality Associated With Acute Respiratory Infections Among Children at Home. <i>J Infect Dis.</i> 2019; <b>219</b>(3): 35864. <a target=xrefwindow id=d60762e1426 href="http://www.ncbi.nlm.nih.gov/pubmed/30165655">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1429 href="https://doi.org/10.1093/infdis/jiy517">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6325348">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d60762e1442 class=n-a></a>Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVaxTM for Prevention of RSV Disease in Infants via Maternal Immunization. Novavax Inc. - IR Site, (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1444 href="https://www.marketwatch.com/press-release/novavax-announces-topline-results-from-phase-3-preparetm-trial-of-resvaxtm-for-prevention-of-rsv-disease-in-infants-via-maternal-immunization-2019-02-28-7184917">Reference Source</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718009158"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1453 class=n-a></a>Blanken MO, Rovers MM, Molenaar JM, <i> et al.</i>: Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. <i>N Engl J Med.</i> 2013; <b>368</b>(19): 17919. <a target=xrefwindow id=d60762e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/23656644">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1467 href="https://doi.org/10.1056/NEJMoa1211917">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718009158">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d60762e1480 class=n-a></a>Simes EAF, Carbonell-Estrany X, Rieger CH, <i> et al.</i>: The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. <i>J Allergy Clin Immunol.</i> 2010; <b>126</b>(2): 25662. <a target=xrefwindow id=d60762e1491 href="http://www.ncbi.nlm.nih.gov/pubmed/20624638">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1494 href="https://doi.org/10.1016/j.jaci.2010.05.026">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718144287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1503 class=n-a></a>Yoshihara S, Kusuda S, Mochizuki H, <i> et al.</i>: Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. <i>Pediatrics.</i> 2013; <b>132</b>(5): 8118. <a target=xrefwindow id=d60762e1514 href="http://www.ncbi.nlm.nih.gov/pubmed/24127479">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1517 href="https://doi.org/10.1542/peds.2013-0982">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718144287">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727261386"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1530 class=n-a></a>Mochizuki H, Kusuda S, Okada K, <i> et al.</i>: Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study. <i>Am J Respir Crit Care Med.</i> 2017; <b>196</b>(1): 2938. <a target=xrefwindow id=d60762e1541 href="http://www.ncbi.nlm.nih.gov/pubmed/28152315">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1544 href="https://doi.org/10.1164/rccm.201609-1812OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727261386">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d60762e1558 class=n-a></a>Scheltema NM, Nibbelke EE, Pouw J, <i> et al.</i>: RSV prevention in infancy and asthma in later life - Authors' reply. <i>Lancet Respir Med.</i> 2018; <b>6</b>(7): e33. <a target=xrefwindow id=d60762e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/29976449">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1572 href="https://doi.org/10.1016/S2213-2600(18)30232-7">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d60762e1581 class=n-a></a>Caballero MT, Jones MH, Karron RA, <i> et al.</i>: The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma. <i>Pediatr Infect Dis J.</i> 2016; <b>35</b>(7): 8202. <a target=xrefwindow id=d60762e1592 href="http://www.ncbi.nlm.nih.gov/pubmed/27351360">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1595 href="https://doi.org/10.1097/INF.0000000000001167">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10611956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1604 class=n-a></a>Ltvall J, Akdis CA, Bacharier LB, <i> et al.</i>: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. <i>J Allergy Clin Immunol.</i> 2011; <b>127</b>(2): 35560. <a target=xrefwindow id=d60762e1615 href="http://www.ncbi.nlm.nih.gov/pubmed/21281866">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1618 href="https://doi.org/10.1016/j.jaci.2010.11.037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10611956">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d60762e1631 class=n-a></a>Hussain SA, Mejias A, Ramilo O, <i> et al.</i>: Post-viral atopic airway disease: pathogenesis and potential avenues for intervention. <i>Expert Rev Clin Immunol.</i> 2019; <b>15</b>(1): 4958. <a target=xrefwindow id=d60762e1642 href="http://www.ncbi.nlm.nih.gov/pubmed/30370798">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1645 href="https://doi.org/10.1080/1744666X.2019.1541737">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d60762e1654 class=n-a></a>Novavax  Creating Tomorrows Vaccines Today. Novavax.com. (Accessed: 28th February 2019). <a target=xrefwindow id=d60762e1656 href="https://novavax.com/">Reference Source</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d60762e1665 class=n-a></a>Lambert SL, Aslam S, Stillman E, <i> et al.</i>: A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective T<sub>H</sub>1-type humoral and cellular immunity in rodent models. <i>PLoS One.</i> 2015; <b>10</b>(3): e0119509. <a target=xrefwindow id=d60762e1679 href="http://www.ncbi.nlm.nih.gov/pubmed/25793508">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1683 href="https://doi.org/10.1371/journal.pone.0119509">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1686 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4368639">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d60762e1696 class=n-a></a>Positive topline data from phase 2 older adult trial and path forward for RSV F vaccine programs. 2017. <a target=xrefwindow id=d60762e1698 href="http://ir.novavax.com/static-files/2e7949dc-f435-47d2-ab21-2082890b5a0f">Reference Source</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d60762e1707 class=n-a></a>GSK Study Register. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1709 href="https://www.gsk-studyregister.com/study/5392">Reference Source</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d60762e1718 class=n-a></a>Respiratory syncytial virus vaccine enters clinical testing. National Institutes of Health (NIH) 2017; (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1720 href="https://www.nih.gov/news-events/news-releases/respiratory-syncytial-virus-vaccine-enters-clinical-testing">Reference Source</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d60762e1729 class=n-a></a>Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1731 href="https://clinicaltrials.gov/ct2/show/NCT02325791">Reference Source</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d60762e1740 class=n-a></a>A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1742 href="https://clinicaltrials.gov/ct2/show/NCT02878330">Reference Source</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727105296"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1751 class=n-a></a>Griffin MP, Khan AA, Esser MT, <i> et al.</i>: Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults. <i>Antimicrob Agents Chemother.</i> 2017; <b>61</b>(3): pii: e01714-16. <a target=xrefwindow id=d60762e1762 href="http://www.ncbi.nlm.nih.gov/pubmed/27956428">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1765 href="https://doi.org/10.1128/AAC.01714-16">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5328523">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727105296">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d60762e1783 class=n-a></a>Robbie GJ, Criste R, Dall'Acqua WF, <i> et al.</i>: A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults. <i>Antimicrob Agents Chemother.</i> 2013; <b>57</b>(12): 614753. <a target=xrefwindow id=d60762e1794 href="http://www.ncbi.nlm.nih.gov/pubmed/24080653">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1797 href="https://doi.org/10.1128/AAC.01285-13">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1801 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3837853">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d60762e1810 class=n-a></a>Dall'Acqua WF, Kiener PA, Wu H: Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). <i>J Biol Chem.</i> 2006; <b>281</b>(33): 2351424. <a target=xrefwindow id=d60762e1818 href="http://www.ncbi.nlm.nih.gov/pubmed/16793771">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1821 href="https://doi.org/10.1074/jbc.M604292200">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d60762e1830 class=n-a></a>Safety, Tolerability, and Pharmacokinetics of MK-1654 in Infants (MK-1654-002). ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1832 href="https://clinicaltrials.gov/ct2/show/NCT03524118">Reference Source</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d60762e1841 class=n-a></a>RSV Investigational Vaccine in RSV-seropositive Infants Aged 12 to 23 Months. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1843 href="https://clinicaltrials.gov/ct2/show/NCT02927873">Reference Source</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d60762e1852 class=n-a></a>Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1854 href="https://clinicaltrials.gov/ct2/show/NCT02040831">Reference Source</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d60762e1863 class=n-a></a>Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV NS2/1313/I1314L or RSV 276 in RSV-Seronegative Infants and Children 6 to 24 Months of Age. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1865 href="https://clinicaltrials.gov/ct2/show/NCT03422237">Reference Source</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d60762e1875 class=n-a></a>Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/M2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1877 href="https://clinicaltrials.gov/ct2/show/NCT03099291">Reference Source</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d60762e1886 class=n-a></a>Polack FP, Stein RT, Custovic A: The syndrome we agreed to call bronchiolitis. <i>J Infect Dis.</i> 2019; pii: jiz082. <a target=xrefwindow id=d60762e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/30783666">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1894 href="https://doi.org/10.1093/infdis/jiz082">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732806508"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1903 class=n-a></a>McFarland EJ, Karron RA, Muresan P, <i> et al.</i>: Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children. <i>J Infect Dis.</i> 2018; <b>217</b>(9): 134755. <a target=xrefwindow id=d60762e1914 href="http://www.ncbi.nlm.nih.gov/pubmed/29509911">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1917 href="https://doi.org/10.1093/infdis/jiy040">Publisher Full Text </a> | <a target=xrefwindow id=d60762e1921 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5894092">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732806508">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d60762e1934 class=n-a></a>A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1936 href="https://clinicaltrials.gov/ct2/show/NCT03303625">Reference Source</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718295562"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e1945 class=n-a></a>Majhen D, Calderon H, Chandra N, <i> et al.</i>: Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field. <i>Hum Gene Ther.</i> 2014; <b>25</b>(4): 30117. <a target=xrefwindow id=d60762e1956 href="http://www.ncbi.nlm.nih.gov/pubmed/24580050">PubMed Abstract </a> | <a target=xrefwindow id=d60762e1959 href="https://doi.org/10.1089/hum.2013.235">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718295562">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d60762e1972 class=n-a></a>A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1974 href="https://clinicaltrials.gov/ct2/show/NCT02491463">Reference Source</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d60762e1984 class=n-a></a>A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV. ClinicalTrials.gov. (Accessed: 25th March 2019). <a target=xrefwindow id=d60762e1986 href="https://clinicaltrials.gov/ct2/show/NCT03213405">Reference Source</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d60762e1995 class=n-a></a>Bueno SM, Gonzlez PA, Cautivo KM, <i> et al.</i>: Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(52): 208227. <a target=xrefwindow id=d60762e2006 href="http://www.ncbi.nlm.nih.gov/pubmed/19075247">PubMed Abstract </a> | <a target=xrefwindow id=d60762e2009 href="https://doi.org/10.1073/pnas.0806244105">Publisher Full Text </a> | <a target=xrefwindow id=d60762e2013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2634951">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727697952"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d60762e2022 class=n-a></a>Rey-Jurado E, Soto J, Glvez N, <i> et al.</i>: A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus. <i>Hum Vaccin Immunother.</i> 2017; <b>13</b>(9): 20927. <a target=xrefwindow id=d60762e2033 href="http://www.ncbi.nlm.nih.gov/pubmed/28598702">PubMed Abstract </a> | <a target=xrefwindow id=d60762e2036 href="https://doi.org/10.1080/21645515.2017.1334026">Publisher Full Text </a> | <a target=xrefwindow id=d60762e2040 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5612508">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727697952">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 02 May 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-610&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-610&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Fundacion INFANT, Buenos Aires, Argentina<br/> <p> <div class=margin-bottom> Sofia Jares Baglivo <br/> <span>Roles: </span> Investigation, Writing  Original Draft Preparation </div> <div class=margin-bottom> Fernando P Polack <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-610/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 02 May 2019, 8:610 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.18749.1">https://doi.org/10.12688/f1000research.18749.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2019 Jares Baglivo S and Polack FP. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=20539 data-id=18749 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18749.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-610/v1/pdf?article_uuid=c37f3128-10b8-43bb-9874-ca73cd6e6f1e" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.18749.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Jares Baglivo S and Polack FP. The long road to protect infants against severe RSV lower respiratory tract illness [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):610 (<a href="https://doi.org/10.12688/f1000research.18749.1" target=_blank>https://doi.org/10.12688/f1000research.18749.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=18749 id=mobile-track-article-signin-18749 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18749?target=/articles/8-610"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20539 /> <input name=articleId type=hidden value=18749 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ralph A Tripp</strong>, Department of Infectious Diseases, University of Georgia, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Giovanni Piedimonte</strong>, Center for Pediatric Research, Lerner Research Institute, The Cleveland Clinic, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 02 May 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-610&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-610&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=49978-47661></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=49979-47662></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-610/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>02 May 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ralph A Tripp</strong>, Department of Infectious Diseases, University of Georgia, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Giovanni Piedimonte</strong>, Center for Pediatric Research, Lerner Research Institute, The Cleveland Clinic, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-610&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-610/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The long road to protect infants against...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-610/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-610/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-610/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Jares Baglivo S and Polack FP');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-610/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-610",
            templates : {
                twitter : "The long road to protect infants against severe RSV lower respiratory.... Jares Baglivo S and Polack FP, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-610/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The long road to protect infants against severe RSV lower respiratory tract illness", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The long road to protect infants against severe RSV lower respiratory tract illness", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/18749/20539")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "20539");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "47661": 0,
                           "47662": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "7e46c51a-899e-4fc5-9142-03c4e7b2d16b";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-610.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-610.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-610.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-610.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-610.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>